Whitehawk Therapeutics, Inc. (WHWK) Institutional Ownership

Ownership Summary

Recent 13F filings as of September 2025 show that 40 institutional investors hold a position in Whitehawk Therapeutics, Inc. (NASDAQ:WHWK).

• These investors collectively held 61.1% of the company's total shares outstanding in September 2025, down from 62.4% in June 2025.
• Quarterly data indicates a 1.21% shift in institutional share volume, and the annual owner count reflects a decrease of 21.57%.
• Among the 40 institutional holders of Whitehawk Therapeutics, 7 added to their stakes while 12 trimmed their positions and 21 held steady.
• The aggregate institutional position in Whitehawk Therapeutics now stands at 28.81Mn shares as of September 2025, after investors increased their holdings (up by 344.99K shares quarter on quarter which is up 16.84Mn shares year over year).
• With 4.62Mn shares, QVT Financial LP commands the largest institutional position in Whitehawk Therapeutics as of September 30, 2025, equating to 9.79% of the company.
• Among the most significant buyers of Whitehawk Therapeutics during September 2025 were STEMPOINT CAPITAL LP (424.08K), Peapod Lane Capital LLC (61.38K), CITADEL ADVISORS LLC (42.91K), VANGUARD GROUP INC (27.62K), Squarepoint Ops LLC (22.29K).
• Leading sellers of Whitehawk Therapeutics stock in September 2025 included BRIDGEWAY CAPITAL MANAGEMENT, LLC (100.00K), JANE STREET GROUP, LLC (80.09K), DIMENSIONAL FUND ADVISORS LP (26.63K), NORTHERN TRUST CORP (20.11K), Stonepine Capital Management, LLC (11.45K).
• The top 10 institutional holders of Whitehawk Therapeutics for the quarter ending September 2025 included QVT Financial LP (4.62Mn), ORBIMED ADVISORS LLC (4.17Mn), SUVRETTA CAPITAL MANAGEMENT, LLC (3.70Mn), ACUTA CAPITAL PARTNERS, LLC (3.41Mn), Avoro Capital Advisors LLC (2.85Mn), Siren, L.L.C. (2.08Mn), Yu Fan (2.07Mn), VANGUARD GROUP INC (1.34Mn), ACORN CAPITAL ADVISORS, LLC (1.14Mn), Ally Bridge Group (NY) LLC (817.94K).